Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 8005 results

  1. Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessment

    In development [GID-HTE10049] Expected publication date: 09 July 2025

    Health technology evaluations
    In development

  2. Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]

    In development [GID-TA11267] Expected publication date: 10 July 2025

    Technology appraisal guidance
    In development

  3. Pulsed field ablation for atrial fibrillation

    In development [GID-IPG10267] Expected publication date: 10 July 2025

    Interventional procedures guidance
    In development

  4. Zanubrutinib for treating relapsed or refractory mantle cell lymphoma after 1 or more treatments [ID6392]

    In development [GID-TA11485] Expected publication date: 10 July 2025

    Technology appraisal guidance
    In development

  5. One-piece closed bags for colostomies: Late Stage Assessment

    In development [GID-HTE10045] Expected publication date: 10 July 2025

    Health technology evaluations
    In development

  6. Avelumab with axitinib for untreated advanced renal cell carcinoma (MA review of TA645) [ID6294]

    In development [GID-TA11587] Expected publication date: 25 June 2025

    Technology appraisal guidance
    In development

  7. Cardiovascular risk assessment and lipid modification

    In development [GID-QS10187] Expected publication date: 23 July 2025

    Quality standard
    In development

  8. Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people aged 6 years and over [ID6372]

    In development [GID-TA11430] Expected publication date: 23 July 2025

    Technology appraisal guidance
    In development

  9. Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive, HER2-negative early breast cancer [ID6153]

    In development [GID-TA11090] Expected publication date: 23 July 2025

    Technology appraisal guidance
    In development

  10. Fruquintinib for previously treated metastatic colorectal cancer [ID6274]

    In development [GID-TA11280] Expected publication date: 23 July 2025

    Technology appraisal guidance
    In development

  11. Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]

    In development [GID-TA11221] Expected publication date: 23 July 2025

    Technology appraisal guidance
    In development

  12. Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]

    In development [GID-TA11220] Expected publication date: 23 July 2025

    Technology appraisal guidance
    In development

  13. Digital front door technologies to gather information for assessments for NHS Talking Therapies for anxiety and depression: Early Value Assessment

    In development [GID-HTE10055] Expected publication date: 24 July 2025

    Health technology evaluations
    In development

  14. Suspected neurological conditions: recognition and referral (NG127)

    This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.

    NICE guideline
    Last updated
    2 October 2023

    Sections for NG127

  15. Safeguarding adults in care homes (NG189)

    This guideline covers keeping adults in care homes safe from abuse and neglect. It includes potential indicators of abuse and neglect by individuals or organisations, and covers the safeguarding process from when a concern is first identified through to section 42 safeguarding enquiries. There are recommendations on policy, training, and care home culture, to improve care home staff awareness of safeguarding and ensure people can report concerns when needed.

    NICE guideline
    Published
    26 February 2021
    View recommendations

    Sections for NG189